OPL-0401

N/A

Report date: 2024/10/29 13:32:21

Base Information

Drug NameOPL-0401
Drug Alias NameOPL-0401
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionRho-associated protein kinase 1 inhibitorsRho-associated protein kinase 2 inhibitorsVascular endothelial growth factor inhibitors
TargetsRho-associated protein kinase 1Rho-associated protein kinase 2Vascular endothelial growth factor
Therapy Area/IndicationsDiabetic Retinopathy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesValo Health Inc
China Registration ClassN/A

Develop Information

Active CompaniesValo Health Inc
Inactive CompaniesN/A
Active IndicationsDiabetic Retinopathy
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A